Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: Single-center experience with 17,956 revascularization procedures (1993-1997)

Texas Heart Institute Journal

Volumn 27, Issue 4, 2000, Pages 337-345

  Angelini, Paolo ^a,b   Vaughn, William K ^a   Zaqqa, Munir ^a   Wilson, James M ^a   Fish, R David ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Atherectomy; Balloon angioplasty; Coronary catheter intervention; Restenosis; Stent angioplasty

Indexed keywords

ADULT; AGED; ARTERY CATHETER; ARTICLE; ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; EXPERIENCE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RESTENOSIS; REVASCULARIZATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034490849     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
2. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study
3. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
4. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
5. Provisional stenting - Stent-like balloon angioplasty: Evidence to define the continuing role of balloon angioplasty for percutaneous coronary revascularization
6. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction
7. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
8. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization
9. Changing outcomes in percutaneous coronary interventions: A study of 34,752 procedures in northern New England, 1990 to 1997
10. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience
11. Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients
12. Impact of an aggressive coronary stenting strategy on the incidence of target lesion revascularization
13. Improved clinical outcome after widespread use of coronary-artery stenting in Canada
14. Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA
15. Optimal angioplasty versus primary stenting (OPUS) [abstract: Late-breaking trials in clinical cardiology]
16. Argentine randomized study optimal coronary balloon angioplasty and stenting vs coronary bypass surgery in multiple vessel disease (ERACI II): In hospital and 30-day results
17. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound
18. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study
19. From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory
20. Doppler and QCA guided aggressive PTCA has the same target lesion revascularization of stent implantation: 6-month-results of the DESTINI study
21. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)
22. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty
23. Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade: Specific considerations by device and disease state
24. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators
25. Frontiers in interventional cardiology
26. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981
27. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial
28. In-stent restenosis: The Washington Hospital Center experience
29. Pathology of acute and chronic coronary stenting in humans
30. Two-year follow-up after catheter-based radiotherapy to inhibit coronary restenosis
31. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems
32. Three-year follow-up after implantation of metallic coronary-artery stents
33. Guidelines for surgical standby for coronary angioplasty: Should they be changed?